ConductScience.org, home

Paper6443576

Advanced prostatic adenocarcinoma: biological aspects and effects of androgen deprivation achieved by castration or agonistic analogues of LHRH.

Tolis G and 5 others. Med Oncol Tumor Pharmacother, 1984. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Advanced prostatic adenocarcinoma: biological aspects and effects of androgen deprivation achieved by castration or agonistic analogues of LHRH. Papers, record 6443576. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6443576

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advanced prostatic adenocarcinoma: biological aspects and effects of androgen deprivation achieved by castration or agonistic analogues of LHRH.
PubMed
Journal
Med Oncol Tumor Pharmacother
PubMed
Year
1984
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.88
iCite
Revised in PubMed
2026-10-11
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tolis GG
2Koutsilieris MM
3Herrera RR
4Stellos AA
5Martinez AA
6Dufresne MM

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
BuserelinMajor topic
OrchiectomyMajor topic
Prostatic NeoplasmsMajor topic
Acid Phosphatase
Alkaline Phosphatase
Bone and Bones
Hormones
Humans
Male
Neoplasm Staging
Prostate
Radiography
Receptors, Androgen
Ultrasonography

Source PubMed

Download CSV of topics

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16800852Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men.Fertil Steril1982https://conductscience.org/library/papers/6800852PubMed
26415631
Transabdominal ultrasonography in the evaluation of patients with advanced prostatic carcinoma: effects of castration and of chronic administration of a gonadotropin releasing hormone agonistic analogue.
Prostate1983https://conductscience.org/library/papers/6415631PubMed
3442131A microassay for the measurement of androgen receptors in human prostatic tissue.Steroids1979https://conductscience.org/library/papers/442131PubMed
46169181Binding of dihydrotestosterone, R 1881 and R 5020 in cytosols from normal, benign hypertrophic and cancerous human prostates.Urol Int1981https://conductscience.org/library/papers/6169181PubMed
56022476Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group.Surg Gynecol Obstet1967https://conductscience.org/library/papers/6022476PubMed
66122893Sustained suppression of testosterone production by the luteinising-hormone releasing-hormone agonist buserelin in patients with advanced prostate carcinoma. A new therapeutic approach?Lancet1982https://conductscience.org/library/papers/6122893PubMed
77388787Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma.Cancer Res1980https://conductscience.org/library/papers/7388787PubMed
8363037Gonadotrophin releasing hormone analogues.Ann Clin Res1978https://conductscience.org/library/papers/363037PubMed
96216468Steroid receptors and hormone responsiveness of human prostatic carcinoma.Prostate1982https://conductscience.org/library/papers/6216468PubMed
106461861Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.Proc Natl Acad Sci U S A1982https://conductscience.org/library/papers/6461861PubMed
114130214Steroids of adrenal origin metabolized by human prostatic tissue both in vivo and in vitro.J Endocrinol1974https://conductscience.org/library/papers/4130214PubMed
1272758Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma.J Clin Endocrinol Metab1977https://conductscience.org/library/papers/72758PubMed
136411994Suppression of testicular steroidogenesis by the GnRH agonistic analogue Buserelin (HOE-766) in patients with prostatic cancer: studies in relation to dose and route of administration.J Steroid Biochem1983https://conductscience.org/library/papers/6411994PubMed
157391080The specific binding of estrogens and androgens to the nuclear matrix of sex hormone responsive tissues.J Biol Chem1980https://conductscience.org/library/papers/7391080PubMed
1788456Steroid receptor content in cytosol from normal and hyperplastic human prostates.J Clin Endocrinol Metab1979https://conductscience.org/library/papers/88456PubMed
18326399Androgen receptors in human prostatic tissues: a review.Cancer Treat Rep1977https://conductscience.org/library/papers/326399PubMed
1976668Androgen binding in cytosols and nuclei of human benign hyperplastic prostatic tissue.J Endocrinol1978https://conductscience.org/library/papers/76668PubMed
20173047Scatchard plots: common errors in correction and interpretation.Steroids1975https://conductscience.org/library/papers/173047PubMed
217062420Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer.J Urol1982https://conductscience.org/library/papers/7062420PubMed
226282069AXC rat prostatic adenocarcinoma: characterization of cells in culture.Adv Exp Med Biol1981https://conductscience.org/library/papers/6282069PubMed

See all 40 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn Papers
6242478An oriented phase-II trial of D-Trp6-LH-RH in patients with prostatic carcinoma.Med Oncol Tumor Pharmacother1984https://conductscience.org/library/papers/6242478

Source PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACP355PubTator's text mininghttps://conductscience.org/library/genes/55NCBI Gene
GNRH12796PubTator's text mininghttps://conductscience.org/library/genes/2796NCBI Gene
PRL5617PubTator's text mininghttps://conductscience.org/library/genes/5617NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6443576

GET https://conductscience.org/api/papers/v1/6443576/references?page=2